Aktiesnakken — Juli 2010
-
bare vent til analytikerne committer deres nye analyser
-
synes det har været generalt for genmab, at man ikke helt når de højder man burde forvente på nyheder
-
59,7
-
fill. Gamechanger
-
Håber virkelig du har ret Aka
-
har ejet mine genmab aktier
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind